ROSEN, ACCREDITED INVESTOR ADVISOR, Encourages Investors in Allarity Therapeutics, Inc. to Inquire About Class Action Securities Investigation – ALLR

New York, New York–(Newsfile Corp. – August 12, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation into potential securities claims on behalf of shareholders of Allarity Therapeutics, Inc. (NASDAQ: ALLR) arising from allegations that Allarity Therapeutics, Inc. may have provided misleading corporate information to the investing public.

SO WHAT: If you purchased Allarity securities, you may be entitled to compensation without paying any out-of-pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action to recover investors’ losses.